Retinoic acid receptors: From molecular mechanisms to cancer therapy

di Masi, Alessandra, Leboffe, Loris, De Marinis, Elisabetta, Pagano, Francesca, Cicconi, Laura, Rochette-Egly, Cécile, Lo-Coco, Francesco, Ascenzi, Paolo, Nervi, Clara·2015·Molecular Aspects of Medicine
DOI 10.1016/j.mam.2014.12.003

Cites (1,341)

Items 1,001–1,200 of 1,341

  1. Therapeutic targets for neuroblastomas
    Garrett M. Brodeur, Radhika Iyer, Jamie L. Courtland, Tiangang Zhuang, Mayumi Higashi, Venkatadri Kolla · 2014 · Expert Opinion on Therapeutic Targets
  2. Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns.
    Arnon Nagler, Irena Riklis, Yehudith Kletter · 1986 · PubMed
  3. FLT3 inhibition as a targeted therapy for acute myeloid leukemia
    Miguel Ángel Sanz, Alan K. Burnett, Francesco Lo‐Coco, Bob Löwenberg · 2009 · Current Opinion in Oncology
  4. Conformationally Defined Retinoic Acid Analogues. 4. Potential New Agents for Acute Promyelocytic and Juvenile Myelomonocytic Leukemias
    Donald D. Muccio, Wayne J. Brouillette, Theodore R. Breitman et al. · 1998 · Journal of Medicinal Chemistry
  5. GCN5 and ADA Adaptor Proteins Regulate Triiodothyronine/GRIP1 and SRC-1 Coactivator-Dependent Gene Activation by the Human Thyroid Hormone Receptor
    Mordecai Anafi, Yong-Fan Yang, Nick A. Barlev, Manjapra V. Govindan, Shelley L. Berger, Tauseef R. Butt, Paul G. Walfish · 2000 · Molecular Endocrinology
  6. Retinoylation of proteins in mammalian cells
    T. R. Breitman, N. Takahashi · 1996 · Biochemical Society Transactions
  7. FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: A report from the Children's Oncology Group
    Matthew A. Kutny, Barry Kurt Moser, Kristina M. Laumann et al. · 2012 · Pediatric Blood & Cancer
  8. Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells
    Shakeel M. Farooqui · 1994 · Life Sciences
  9. Altered Retinoic Acid Sensitivity and Temporal Expression of Hox Genes in Polycomb-M33-Deficient Mice
    Sophie Bel-Vialar, Nathalie Coré, Rémi Terranova, Véronica Goudot-Crozel, Annie Boned, Malek Djabali · 2000 · Developmental Biology
  10. Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention
    Michelle A.T. Hildebrandt, Scott Michael Lippman, Carol Jean Etzel, Edward Kim, J. Jack Lee, Fadlo Raja Khuri, Margaret R. Spitz, Reuben Lotan, Waun Ki Hong, Xifeng Wu · 2012 · Clinical Cancer Research
  11. The solution structure of the human retinoic acid receptor-β DNA-binding domain
    Ronald M. A. Knegtel, Masato Katahira, Johannes G. Schilthuis, Alexandre M. J. J. Bonvin, Rolf Boelens, Douglas W. Eib, Paul T. van der Saag, Robert Kaptein · 1993 · Journal of Biomolecular NMR
  12. Topical Tretinoin Therapy and All-Cause Mortality
    Martin A. Weinstock · 2009 · Archives of Dermatology
  13. Nuclear receptor superfamily: Principles of signaling
    Germain, Pierre, Altucci, Lucia, Bourguet, William, Rochette-Egly, C., Gronemeyer, Hinrich · 2003 · Pure and Applied Chemistry
  14. Phosphorylation of the Retinoid X Receptor at the Omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity
    Bruck, Nathalie, Bastien, Julie, Bour, Gaétan, Tarrade, Anne, Plassat, Jean-Luc, Bauer, Annie, Adam-Stitah, Sylvie, Rochette-Egly, Cécile · 2005 · Cellular Signalling
  15. Multi-Stage Program of Differentiation in Human Epidermal Keratinocytes: Regulation by Retinoids
    Anton M. Jetten · 1990 · Journal of Investigative Dermatology
  16. Breakpoint clusters of the PML gene in acute promyelocytic leukemia: Primary structure of the reciprocal products of the PML‐RARA gene in a patient with t(15;17)
    Shuo Dong, Geng Jp, Jia‐Hua Tong et al. · 1993 · Genes Chromosomes and Cancer
  17. Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen
    Vikram Mathews, M. Thomas, Vivi M. Srivastava · 2007 · Haematologica
  18. Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma
    Stephen Anthony Boorjian, Matthew I. Milowsky, Jodi Kaplan, Martin Albert, Marta Vallee Cobham, Deirdre M. Coll, Nigel Patrick Mongan, Gary Shelton, Daniel Peter Petrylak, Lorraine J. Gudas et al. · 2007 · Journal of Immunotherapy
  19. Negative regulation of hormone signaling by RIP140
    Patrick Augereau, Éric Badia, Patrick Balaguer, Sophie Carascossa, Audrey Castet‐Nicolas, Stéphan Jalaguier, Vincent Cavaillès · 2006 · The Journal of Steroid Biochemistry and Molecular Biology
  20. Comparison of selective retinoic acid receptor– and retinoic X receptor–mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma
    Christiane Querfeld, Steven T. Rosen, Joan Guitart, ALFRED W. RADEMAKER, Bing B Fung, William Posten, Timothy M. Kuzel · 2004 · Journal of the American Academy of Dermatology
  21. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Roberto Marasca, Patrizia Zucchini, Sara Galimberti · 1999 · PubMed
  22. Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho).
    Hisashi Fukutani, Takashi Naoe, R Ohno · 1995 · PubMed
  23. Decreased retinoid concentration and retinoid signalling pathways in human atopic dermatitis
    Johanna Mihály, Anat Gamlieli, Margitta Worm, Ralph Rühl · 2011 · Experimental Dermatology
  24. Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion
    Satish Cheepala, Weihong Yin, Zanobia Syed, Jennifer N. Gill, Alaina McMillian, Heather E. Kleiner, Mark John Lynch, Rasiah Loganantharaj, Marjan Trutschl, Urška Cvek et al. · 2009 · Molecular Cancer
  25. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers
    Clinton J. Grubbs, Ronald A. Lubet, Venkatram R. Atigadda et al. · 2005 · Carcinogenesis
  26. Reduced retinoids and retinoid receptors' expression in pancreatic cancer: A link to patient survival
    Tim Bleul, Ralph Rühl, Svetlana Bulashevska, Svetlana Karakhanova, Jens Werner, Alexandr V. Bazhin · 2014 · Molecular Carcinogenesis
  27. A Novel Retinoic Acid Receptor β Isoform and Retinoid Resistance in Lung Carcinogenesis
    William Jeffrey Petty, Na Li, Adrian Biddle · 2005 · JNCI Journal of the National Cancer Institute
  28. Vinexin β Interacts with the Non-phosphorylated AF-1 Domain of Retinoid Receptor γ (RARγ) and Represses RARγ-mediated Transcription
    Gaétan Bour, Jean‐Luc Plassat, Annie Bauer, Sébastien Lalevée, Cécile Rochette‐Egly · 2005 · Journal of Biological Chemistry
  29. Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis
    Nitin Chakravarti, Reuben Lotan, Abdul Hafeez Diwan, Carla L. Warneke, Marcella M. Johnson, Victor Gerardo Prieto · 2007 · Clinical Cancer Research
  30. Comparison of 13-cis-retinoic acid to trans-retinoic acid using human neuroblastoma cell lines.
    C. Patrick Reynolds, Pia Schindler, Dan M. Jones · 1994 · PubMed
  31. Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy
    Charles G. Drake, Padmanee Sharma, Winald R. Gerritsen · 2013 · Oncogene
  32. Akt phosphorylates and suppresses the transactivation of retinoic acid receptor α
    Srinivas, Harish, Xia, Dianren, Moore, Nicole L., Uray, Ivan P., Kim, Heetae, Ma, Long, Weigel, Nancy L., Brown, Powel H., Kurie, Jonathan M. · 2006 · Biochemical Journal
  33. Human TAF II 55 Interacts with the Vitamin D 3 and Thyroid Hormone Receptors and with Derivatives of the Retinoid X Receptor That Have Altered Transactivation Properties
    Anne-Claire Lavigne, Gabrielle Mengus, Yann‐Gaël Gangloff, Jean‐Marie Wurtz, Irwin Davidson · 1999 · Molecular and Cellular Biology
  34. Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression.
    N. Le May, I. Iltis, J. Amé, A. Zhovmer, D. Biard, J. Egly, V. Schreiber, F. Coin · 2012 · Molecules and Cells
  35. Polycomb recruitment attenuates retinoic acid–induced transcription of the bivalent NR2F1 gene
    Kristian Bruun Laursen, Nigel Patrick Mongan, Yong Zhuang, Mary M. Ng, Yannick D. Benoit, Lorraine J. Gudas · 2013 · Nucleic Acids Research
  36. All-trans retinoic acid (atRA) differentially induces apoptosis in matched primary and metastatic melanoma cells - a speculation on damage effect of atRA via mitochondrial dysfunction and cell cycle redistribution
    Hong Zhang · 2003 · Carcinogenesis
  37. All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemia.
    Adriano Venditti, Roberto Stasi, Giovanni Del Poeta, Francesco Buccisano, Germano Aronica, Antonio Bruno, F Pisani, Tommaso Caravita, M Masi, M Tribalto · 1995 · PubMed
  38. Effects of topical tretinoin on dysplastic nevi.
    Allan C. Halpern, Lynn Mara Schuchter, David E. Elder · 1994 · Journal of Clinical Oncology
  39. Phase I Clinical and Pharmacologic Study of 13-cis-Retinoic Acid, Interferon Alfa, and Paclitaxel in Patients With Prostate Cancer and Other Advanced Malignancies
    Robert S. DiPaola, Mohamed M. Rafi, Viral P. Vyas, DL Toppmeyer, Eric H. Rubin, J. Patel, Susan Goodin, M. Medina, P. Medina, Rita Zamek et al. · 1999 · Journal of Clinical Oncology
  40. Systematic review of combination therapies for mycosis fungoides
    Daniel Humme, Alexander Nast, RICARDO ERDMANN · 2014 · Cancer Treatment Reviews
  41. Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation.
    Thomas M. Vollberg, Clara Nervi, M D George, Wataru Fujimoto, Andrée Krust, Anton M. Jetten · 1992 · Molecular Endocrinology
  42. Interactions that determine the assembly of a retinoid X receptor/corepressor complex
    Jagadish C. Ghosh, Xiaofang Yang, Aihua Zhang, Millard H. Lambert, Hui Li, H. Eric Xu, J. Don Chen · 2002 · Proceedings of the National Academy of Sciences
  43. Acute Promyelocytic Leukemia — Weapons of Mass Differentiation
    Jonathan D. Licht · 2009 · New England Journal of Medicine
  44. Long FLT3 internal tandem duplications and reduced PML-RAR expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients
    Carmen Chillón, Carlos Santamaría, Ramón García‐Sánz et al. · 2010 · Haematologica
  45. Up-regulation of retinoic acid receptor beta expression in renal cancers in vivo correlates with response to 13-cis-retinoic acid and interferon-alpha-2a.
    William J. Berg, David M. Nanus, A Leung, Karen T. Brown, B Hutchinson, Madhu Mazumdar, Xiao Xu, Reuben Lotan, Victor E. Reuter, Robert John Motzer · 1999 · PubMed
  46. RARα1/RARα2-PML mRNA Expression in Acute Promyelocytic Leukemia Cells: A Molecular and Laboratory-Clinical Correlative Study
    Yunping Li, Janet Andersen, Arthur Zelent · 1997 · Blood
  47. Systemic retinoids for chemoprevention of non-melanoma skin cancer in high-risk patients.
    Christina B. Marquez, S. Bair, Erica Smithberger, Basil S. Cherpelis, Lewis Frank Glass · 2010 · PubMed
  48. Retinoic acid activation and thyroid hormone repression of the human alcohol dehydrogenase gene ADH3.
    P.P. Harding, Gregg Duester · 1992 · Journal of Biological Chemistry
  49. LIM protein Ajuba functions as a nuclear receptor corepressor and negatively regulates retinoic acid signaling
    Zhaoyuan Hou, Hongzhuang Peng, David E. White, Dmitri G. Negorev, Gerd G. Maul, Yunfeng Feng, Gregory D. Longmore, Samuel Waxman, Arthur Zelent, Frank J. Rauscher · 2010 · Proceedings of the National Academy of Sciences
  50. Targeting the PML/RARα translocation product triggers apoptosis in promyelocytic leukemia cells
    Kathryn Nason-Burchenal, Garry Β. Takle, Umberto Pace, Sandra Flynn, Janet J. Allopenna, Patrick Martin, Shaji T. George, Allan R. Goldberg, Ethan Dmitrovsky · 1998 · Oncogene
  51. Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status
    Roberto Marasca, Rossana Maffei, Patrizia Zucchini, I Castelli, Alessia Saviola, Silvia Martinelli, A Ferrari, Marcella Fontana, Sara Ravanetti, Giovanni Fernando Torelli · 2005 · Leukemia
  52. Redox Control of Retinoic Acid Receptor Activity: A Novel Mechanism for Retinoic Acid Resistance in Melanoma Cells
    Kristian C. Demary, Ling Wong, James S. Liou, Douglas V. Faller, Remco A. Spanjaard · 2001 · Endocrinology
  53. Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
    Giuseppe G.M. Leone, Francesco D’Alò, Giuseppe Zardo, Maria Teresa Voso, Clara Nervi · 2008 · Current Medicinal Chemistry
  54. Differentiation Therapy for Acute Promyelocytic Leukemia
    Pierre Fenaux, Laurent Degos · 1997 · New England Journal of Medicine
  55. A phase 2 trial of all‐trans‐retinoic acid in combination with interferon‐α2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study
    Peter C. Adamson, Katherine K. Matthay, Michelle O'Brien · 2006 · Pediatric Blood & Cancer
  56. Effects of Strain and Treatment with Inhaled All-Trans-Retinoic Acid on Cigarette Smoke-Induced Pulmonary Emphysema in Mice
    Thomas H. March, Larry E. Bowen, Gregory L. Finch, Kristen J. Nikula, Bonnie J. Wayne, CHARLES H. HOBBS · 2005 · COPD Journal of Chronic Obstructive Pulmonary Disease
  57. Involvement of the SMRT/NCoR–HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4–Not complex
    Sandrine Jayne, Carin G. M. Zwartjes, Frederik M. A. van Schaik, H. T. Marc Timmers · 2006 · Biochemical Journal
  58. Cyclin H binding to the RARα activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7
    Bour, Gaétan, Gaillard, Emilie, Bruck, Nathalie, Lalevée, Sébastien, Plassat, Jean-Luc, Busso, Didier, Samama, Jean-Pierre, Rochette-Egly, Cécile · 2005 · Proceedings of the National Academy of Sciences
  59. Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme
    Victor A. Levin, Pierre Giglio, Vinay K. Puduvalli, Jacob L. Jochec, Morris D. Groves, W.K. Alfred Yung, Kenneth R. Hess · 2005 · Journal of Neuro-Oncology
  60. Use of All-trans Retinoic Acid in Combination with Arsenic Trioxide for Remission Induction in Patients with Newly Diagnosed Acute Promyelocytic Leukemia and for Consolidation/Maintenance in CR Patients
    Chong-Wen Dai, Guangsen Zhang, Jian-kai Shen, Wenli Zheng, Min-Fei Pei, Yunxiao Xu, Yixiong Cao, Yan Yi, Junjie Yang, Hongling Peng et al. · 2009 · Acta Haematologica
  61. DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia
    Glasow, Annegret, Barrett, Angela, Petrie, Kevin, Gupta, Rajeev, Boix-Chornet, Manuel, Zhou, Da-Cheng, Grimwade, David, Gallagher, Robert, von Lindern, Marieke, Waxman, Samuel et al. · 2008 · Blood
  62. Functional Interaction Between a RARE and an AP-2 Binding Site in the Regulation of the Human HOX A4 Gene Promoter
    L. F. Doerksen, Anuradha Bhattacharya, Perry Kannan, D. Pratt, Michael A. Tainsky · 1996 · Nucleic Acids Research
  63. Cross Talk between Retinoic Acid Signaling and Transcription Factor GATA-2
    Shinobu Tsuzuki, Kenji Kitajima, Toru Nakano, Annegret Glasow, Arthur Zelent, Tariq Enver · 2004 · Molecular and Cellular Biology
  64. A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group
    Melissa M. Moore, Martin R. Stockler, Robert S. C. Lim · 2010 · Cancer Chemotherapy and Pharmacology
  65. The Rexinoid LG100268 Prevents the Development of Preinvasive and Invasive Estrogen Receptor–Negative Tumors in MMTV-erbB2 Mice
    Yuxin Li, Yun Zhang, Jamal L. Hill, Qiang Shen, Hee-Tae Kim, Xiaochun Xu, Susan Galloway Hilsenbeck, Reid Paul Bissonnette, William W. Lamph, Powel H. Brown · 2007 · Clinical Cancer Research
  66. The Drug-Induced Degradation of Oncoproteins: An Unexpected Achilles' Heel of Cancer Cells?
    Ablain, Julien, Nasr, Rihab, Bazarbachi, Ali, de Thé, Hugues · 2011 · Cancer Discovery
  67. Components of the CCR4-NOT Complex Function as Nuclear Hormone Receptor Coactivators via Association with the NRC-interacting Factor NIF-1
    Shivani Garapaty, MaryAnn Mahajan, Herbert H. Samuels · 2008 · Journal of Biological Chemistry
  68. Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia.
    Michael Lishner, John E. Curtis, Salomon Minkin, McCulloch Ea · 1989 · PubMed
  69. Conditional RARα knockout mice reveal acute requirement for retinoic acid and RARα in homeostatic plasticity
    Federica Sarti, Jessica Schroeder, Jason N. Aoto, Lu Chen · 2012 · Frontiers in Molecular Neuroscience
  70. Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?
    Massimiliano Cazzaniga, Clara Varricchio, Chiara Montefrancesco · 2012 · BioMed Research International
  71. Clinical and Biological Significance of CD56 Antigen Expression in Acute Promyelocytic Leukemia
    Shigeki Ito, Yoji Ishida, Tatsuo Oyake et al. · 2004 · Leukemia & lymphoma/Leukemia and lymphoma
  72. Retinoic acid modulates intrahippocampal levels of corticosterone in middle-aged mice: consequences on hippocampal plasticity and contextual memory
    Damien Bonhomme, Véronique Pallet, Gaëlle Dominguez, Laure Servant, Nadia Henkous, Pauline Lafenêtre, Paul Higueret, Daniel Béracochéa, Katia Touyarot · 2014 · Frontiers in Aging Neuroscience
  73. Global Assessment of Genetic Variation Influencing Response to Retinoid Chemoprevention in Head and Neck Cancer Patients
    J. Jack Lee, Xifeng Wu, Michelle A.T. Hildebrandt, Hushan Yang, Fadlo Raja Khuri, Edward Kim, Jian Hong Gu, Yuanqing Ye, Reuben Lotan, Margaret R. Spitz et al. · 2011 · Cancer Prevention Research
  74. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells
    LS Rusten, Ingunn Dybedal, HK Blomhoff, Rune Blomhoff, EB Smeland, Sten Eirik W. Jacobsen · 1996 · Blood
  75. Structure of the human cellular retinoic acid-binding protein II gene. Early transcriptional regulation by retinoic acid.
    Anders Åström, U Pettersson, John J. Voorhees · 1992 · Journal of Biological Chemistry
  76. Nuclear localization of the human mutY homologue hMYH
    Jyy-Jih Tsai-Wu, Ho‐Ting Su, Yalei Wu, Su-Ming Hsu, C.H. Herbert Wu · 2000 · Journal of Cellular Biochemistry
  77. Transcriptional targeting by microRNA-Polycomb complexes: A novel route in cell fate determination
    Giuseppe Zardo, Alberto Ciolfi, Laura Vian, Monia Billi, Serena Racanicchi, Francesco Grignani, Clara Nervi · 2012 · Cell Cycle
  78. Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer
    Donna M. Peehl, David Feldman · 2004 · The Journal of Steroid Biochemistry and Molecular Biology
  79. Human ADA3 Binds to Estrogen Receptor (ER) and Functions As a Coactivator for ER-mediated Transactivation
    Gaoyuan Meng, Yongtong Zhao, Alo Nag, Mu‐Sheng Zeng, Goberdhan P. Dimri, Qingshen Gao, David E. Wazer, Rakesh Kumar, Hamid Band, Vimla Band · 2004 · Journal of Biological Chemistry
  80. Mouse and human retinoic acid receptor β2 promoters: sequence comparison and localization of retinoic acid responsiveness
    Sanbing Shen, Frank A.E. Kruyt, Jeroen Den Hertoc, Paul T. van der Saag, Wiebe Kruljer · 1991 · DNA sequence
  81. Linking Covalent Histone Modifications to Epigenetics: The Rigidity and Plasticity of the Marks
    Yanming Wang, Joanna Wysocka, Julie R. Perlin, Lauriebeth Leonelli, C. David Allis, Scott Alexander Coonrod · 2004 · Cold Spring Harbor Symposia on Quantitative Biology
  82. 13-cis-Retinoic Acid in Combination with Gemcitabine in the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — Report of a Pilot Phase II Study
    Agnieszka Michael, Mark E. Hill, Anthony Maraveyas, Angus George Dalgleish, Fiona J. Lofts · 2006 · Clinical Oncology
  83. Connexin-dependent gap junction enhancement is involved in the synergistic effect of sorafenib and all-trans retinoic acid on HCC growth inhibition
    Yan Fang Yang, Shukui Qin, Qiong Wu · 2013 · Oncology Reports
  84. Fetal Death and Maldevelopment Resulting from Maternal Vitamin A Deficiency in the Rat.∗
    James G. Wilson, Stephanie Barch · 1949 · Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine
  85. The retinoic acid receptors RARα and RARγ are required for inner ear development
    R. Romand, Eri Hashino, Pascal Dollé, Jean‐Luc Vonesch, Pierre Chambon, Norbert B. Ghyselinck · 2002 · Mechanisms of Development
  86. 9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers
    Clinton J. Grubbs, Donald L. Hill, Kirby I. Bland, Samuel W. Beenken, Tsu‐Han Lin, Isao Eto, Venkatram R. Atigadda, Kimberly K. Vines, Wayne J. Brouillette, Donald D. Muccio · 2003 · Cancer Letters
  87. The Structure of Apo-wild-type Cellular Retinoic Acid Binding Protein II at 1.4 Å and its Relationship to Ligand Binding and Nuclear Translocation
    Soheila Vaezeslami, Erika Mathes Lisabeth, Chrysoula Vasileiou, Babak Borhan, James H. Geiger · 2006 · Journal of Molecular Biology
  88. Characterization of the Retinoid Binding Properties of the Major Fusion Products Present in Acute Promyelocytic Leukemia Cells
    Laura Benedetti, Arthur A. Levin, Bianca Maria Scicchitano, Francesco Grignani, Gary Allenby, Daniela Diverio, Francesco Lo‐Coco, Giuseppe Avvisati, Martin Ruthardt, Sergio Adamo et al. · 1997 · Blood
  89. CCAAT-enhancer-binding protein α (C/EBPα) is required for the thyroid hormone but not the retinoic acid induction of phosphoenolpyruvate carboxykinase (PEPCK) gene transcription
    Edwards A. Park, Shulan Song, Michelle Olive, William J. Roesler · 1997 · Biochemical Journal
  90. Tazarotene: Randomized, Double-Blind, Vehicle-Controlled, and Open-Label Concurrent Trials for Basal Cell Carcinoma Prevention and Therapy in Patients with Basal Cell Nevus Syndrome
    Jean Yuh Tang, Albert Sean Chiou, Julian M Mackay-Wiggan, Michelle Aszterbaum, Anita M. Chanana, Wayne Lee, Joselyn Lindgren, Maria Acosta Raphael, Bobbye Jo Thompson, David R. Bickers et al. · 2014 · Cancer Prevention Research
  91. Retinoylation of cytokeratins in normal human epidermal keratinocytes
    Noriko K. Takahashi, Anton M. Jetten, Theodore R. Breitman · 1991 · Biochemical and Biophysical Research Communications
  92. Identification and Characterization of Nucleolin as a COUP-TFII Coactivator of Retinoic Acid Receptor β Transcription in Breast Cancer Cells
    Lacey M. Litchfield, Krista A. Riggs, Alyson M. Hockenberry et al. · 2012 · PLoS ONE
  93. Retinoylation of proteins in leukemia, embryonal carcinoma, and normal kidney cell lines: Differences associated with differential responses to retinoic acid
    Noriko K. Takahashi, Theodore R. Breitman · 1991 · Archives of Biochemistry and Biophysics
  94. Emerging insights into the coactivator role of NCoA62/SKIP in Vitamin D-mediated transcription
    Paul N. MacDonald, Diane R. Dowd, Chi Zhang, Chun Gu · 2004 · The Journal of Steroid Biochemistry and Molecular Biology
  95. Identification of the molecular requirements for an RARα-mediated cell cycle arrest during granulocytic differentiation
    Carl R. Walkley, Louise E. Purton, Hayley J. Snelling, Yang-Dar Yuan, Hideaki Nakajima, Pierre Chambon, Roshantha A.S. Chandraratna, Grant A. McArthur · 2003 · Blood
  96. PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
    Lars Bullinger, Richard F. Schlenk, Marlies Götz, Ursula Botzenhardt, Susanne Hofmann, Annika C. Russ, Anna Babiak, Lu Zhang, Vanessa Schneider, Konstanze Döhner et al. · 2013 · Clinical Cancer Research
  97. Structure of a Thyroid Hormone Receptor DNA-Binding Domain Homodimer Bound to an Inverted Palindrome DNA Response Element
    Yi Chen, Matthew Adam Young · 2010 · Molecular Endocrinology
  98. Retinoic acid signaling and the initiation of mammary gland development
    Kyoung‐Won Cho, Hyuk Jae Kwon, Jeong-Oh Shin, Jong‐Min Lee, Sung Won Cho, Cheryll A. Tickle, Han-Sung Jung · 2012 · Developmental Biology
  99. The N-terminal of the estrogen receptor (ERα) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells
    Caroline Rousseau, Filippa Pettersson, Marie-Claude Couture, André Paquin, Jacques Galipeau, Sylvie Mader, Wilson H. Miller · 2003 · The Journal of Steroid Biochemistry and Molecular Biology
  100. Lineage Promiscuity and Plasticity in Hematopoietic Development
    Koichi Akashi · 2005 · Annals of the New York Academy of Sciences
  101. The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha
    Manuela Occhionorelli, Fabio Santoro, Isabella Pallavicini, Alicja Gruszka, S Moretti, Daniela Bossi, Andrea Viale, Danielle C. Shing, Simona Ronzoni, Ivan Muradore et al. · 2011 · Leukemia
  102. N-(4-hydroxyphenyl)retinamide (Fenretinide) in combination with retinoic acid enhances differentiation and retinoylation of proteins.
    Noriko K. Takahashi, Edward A. Sausville, T. R. Breitman · 1995 · PubMed
  103. The cytokines IL-3 and GM-CSF regulate the transcriptional activity of retinoic acid receptors in different in vitro models of myeloid differentiation
    Barton S. Johnson, LeMoyne Mueller, Jutong Si, Steven John Collins · 2002 · Blood
  104. Reciprocal roles of SIRT1 and SKIP in the regulation of RAR activity: implication in the retinoic acid-induced neuronal differentiation of P19 cells
    Moo Rim Kang, Sang-Wang Lee, Elisa Um, Hyun Tae Kang, Eun Seong Hwang, Eunjoo Kim, Soo‐Jong Um · 2009 · Nucleic Acids Research
  105. RARα1/RARα2-PML mRNA Expression in Acute Promyelocytic Leukemia Cells: A Molecular and Laboratory-Clinical Correlative Study
    Yun Li, Janet Andersen, Arthur Zelent · 1997 · Blood
  106. Inhibition of carcinogenesis by retinoids.
    Paul Nettesheim · 1980 · PubMed
  107. Oral premalignant lesions
    William N. William · 2012 · Current Opinion in Oncology
  108. The changing paradigm of prognostic factors in acute myeloid leukaemia
    David J. Grimwade · 2012 · Best Practice & Research Clinical Haematology
  109. Down-Regulation of the Tumor Suppressor Gene Retinoic Acid Receptor β2 through the Phosphoinositide 3-Kinase/Akt Signaling Pathway
    Bruno Lefebvre, Céline Brand, Sébastien Flajollet · 2006 · Molecular Endocrinology
  110. Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif
    Brunangelo Falini, Elena Albiero, Niccolò Bolli, Mol Marco, Domenico Madeo, Maria Paola Martelli, Ildo Nicoletti, Francesco Rodeghiero · 2007 · Leukemia
  111. Retinoids Regulate the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer Cells
    Linda S. Kelsey, Parul Katoch, Kristen E. Johnson, Surinder K. Batra, Parmender P. Mehta · 2012 · PLoS ONE
  112. Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells
    Niu, Chao Shi, Li, Ming Wu, Ni, Yong Feng, Chen, Jian Min, Mei, Jia Ming, Li, Jing, Fu, Xian Ming · 2010 · Journal of Experimental & Clinical Cancer Research
  113. Retinoylation of vimentin in the human myeloid leukemia cell line HL60.
    Noriko K. Takahashi, T. R. Breitman · 1994 · Journal of Biological Chemistry
  114. Phosphodiesterase IV Inhibition by Piclamilast Potentiates the Cytodifferentiating Action of Retinoids in Myeloid Leukemia Cells
    Edoardo Parrella, Maurizio Gianni’, Virginia Cecconi, Elisa Agnese Nigro, Maria Monica Barzago, Alessandro Rambaldi, Cécile Rochette‐Egly, Mineko Terao, Enrico Garattini · 2004 · Journal of Biological Chemistry
  115. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
    Guisheng Yang, Mark David Minden, E. A. McCulloch · 1993 · PubMed
  116. To Die or Not to Die: A HAT Trick
    Sandrine Tyteca, Gaëlle Legube, Didier Trouche · 2006 · Molecular Cell
  117. Response of SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) and N-CoR (Nuclear Receptor Corepressor) Corepressors to Mitogen-Activated Protein Kinase Kinase Kinase Cascades Is Determined by Alternative mRNA Splicing
    Jonas, Brian A., Varlakhanova, Natalia, Hayakawa, Fumihiko, Goodson, Michael, Privalsky, Martin L. · 2007 · Molecular Endocrinology
  118. In vivo imaging of retinoic acid receptor β2 transcriptional activation by the histone deacetylase inhibitor MS‐275 in retinoid‐resistant prostate cancer cells
    David Z. Qian, Mingqiang Ren, Yongfeng Wei, Xiaofei Wang, Fleur van de Geijn, Camilla Sandvad Rasmussen, Osamu Nakanishi, Nicoletta Sacchi, Роберто Пили · 2005 · The Prostate
  119. All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells
    Kawin Leelawat, Kenoki Ohuchida, Kazuhiro Mizumoto · 2004 · Cancer Letters
  120. A Pilot, First-in-Human, Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers
    Jill Kolesar, Ryan J. Hoel, Marcia L Pomplun, Tom Havighurst, Jeanne Stublaski, Barbara W. Wollmer, Helen Krontiras, Wayne J. Brouillette, Donald D. Muccio, KyungMann Kim et al. · 2010 · Cancer Prevention Research
  121. Novel mutation in the PML/RARα chimeric gene exhibits dramatically decreased ligand-binding activity and confers acquired resistance to retinoic acid in acute promyelocytic leukemia
    Nobuyuki Takayama, Masahiro Kizaki, Takayuki Hida, Kentaro Kinjo, Yasuo Ikeda · 2001 · Experimental Hematology
  122. Chalcone carboxylic acids. Potent differentiation inducers of human promyelocytic cells HL-60.
    Koichi Shudo, Hiroyuki Kagechika, Emiko Kawachi · 1985 · Chemical and Pharmaceutical Bulletin
  123. Lung Cancer and Vitamin Supplementation
    William J. Blot, Junyao Li, Philip R. Taylor · 1994 · New England Journal of Medicine
  124. Defective expression of cellular retinol binding protein type 1 and retinoic acid receptors α2, β2, and ǵ2 in human breast cancer cells
    Yongkui Jing, Jie Zhang, Ira J. Bleiweiss, Samuel Waxman, Arthur Zelent, Rafael Mira-y-Lopez · 1996 · The FASEB Journal
  125. Serum vitamins A and E and carotene in patients with gynecologic cancer
    Pentti K. Heinonen, Tapio A. Kuoppala, Timo T. Koskinen · 1987 · Archives of Gynecology and Obstetrics
  126. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines
    Roberto Enrico Favoni, Alessandra de Cupis, Silvia Bruno, Douglas Yee, A Ferrera, P Pirani, A. Costa, Andrea DeCensi · 1998 · British Journal of Cancer
  127. Biology and treatment of acute promyelocytic leukemia
    Pierre Fenaux, Christine Chomienne · 1996 · Current Opinion in Oncology
  128. A Phase I-II Preoperative Biomarker Trial of Fenretinide in Ascitic Ovarian Cancer
    Nicoletta Colombo, Franca Formelli, Maria Grazia Cantù et al. · 2006 · Cancer Epidemiology Biomarkers & Prevention
  129. The role of targeted therapies in the management of progressive glioblastoma
    Jeffrey J. Olson, Lakshmi Nayak, David Ryan Ormond, Patrick Yung Wen, Steven N. Kalkanis, Timothy Charles Ryken · 2014 · Journal of Neuro-Oncology
  130. Differential regulation of drug transporter expression by all-trans retinoic acid in hepatoma HepaRG cells and human hepatocytes
    Marc Le Vée, Elodie Jouan, Bruno Stieger, Olivier Fardel · 2013 · European Journal of Pharmaceutical Sciences
  131. Interleukin-2 and 13-cis retinoic acid as maintenance therapy in advanced ovarian cancer
    F. Recchia, Gaetano Saggio, Alisia Cesta · 2005 · International Journal of Oncology
  132. Understanding the multiple biological aspects leading to myeloma
    Eileen Mary Boyle, Faith E. Davies, Xavier P Leleu, Gareth John Morgan · 2014 · Haematologica
  133. Ichthyosiform dermatosis with superficial blister formation and peeling: Evidence for a desmosomal anomaly and altered epidermal vitamin A metabolism
    B. Mevorah, Oscar Daniel Salomón, Georges Siegenthaler · 1996 · Journal of the American Academy of Dermatology
  134. RARβ2 specificity in mediating RA inhibition of growth of lung cancer-derived cells
    André Toulouse · 2000 · Lung Cancer
  135. Characterization of retinyl beta-glucuronide in human blood
    Arun B. Barua, Ramiro Orlando Batres, J A Olson · 1989 · American Journal of Clinical Nutrition
  136. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide
    Hiromitsu Jinno · 1999 · Carcinogenesis
  137. Regulation of Type I and Type II Transglutaminase in Normal Human Bronchial Epithelial and Lung Carcinoma Cells
    Thomas M. Vollberg, Margaret D. George, Clara Nervi, Anton M. Jetten · 1992 · American Journal of Respiratory Cell and Molecular Biology
  138. Retinoic acid and IFN inhibition of cell proliferation is associated with apoptosis in squamous carcinoma cell lines: role of IRF-1 and TGase II-dependent pathways.
    Valeria Giandomenico, Francesca Lancillotti, Gianna Fiorucci, Zulema Antonia Percario, Roberto Rivabene, Walter Malorni, Elisabetta Affabris, G. Romeo · 1997 · PubMed
  139. Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels
    Aleix Prat, Marta Parera, Bárbara Adamo · 2008 · Annals of Oncology
  140. Identification of DNA rearrangements at the retinoic acid receptor- alpha (RAR-alpha) locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RAR-alpha second intron. Italian Cooperative Study Group "GIMEMA"
    Daniela Diverio, F Lo Coco, Francesca D'adamo · 1992 · Blood
  141. Suppressive Effect of Receptor-interacting Protein 140 on Coregulator Binding to Retinoic Acid Receptor Complexes, Histone-modifying Enzyme Activity, and Gene Activation
    Xinli Hu, Yixin Chen, Mariya Farooqui, Mary C. Thomas, Cheng‐Ming Chiang, Li‐Na Wei · 2003 · Journal of Biological Chemistry
  142. Retinoic Acid Receptor-α Is Stabilized in a Repressive State by Its C-Terminal, Isotype-Specific F Domain
    Behnom Farboud, Martin L. Privalsky · 2004 · Molecular Endocrinology
  143. Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response
    Ferry, Christine, Gaouar, Samia, Fischer, Benoit, Boeglin, Marcel, Paul, Nicodeme, Samarut, Eric, Piskunov, Aleksandr, Pankotai-Bodo, Gabriella, Brino, Laurent, Rochette-Egly, Cecile · 2011 · Proceedings of the National Academy of Sciences
  144. Nuclear Receptor Coactivators Facilitate Vitamin D Receptor Homodimer Action on Direct Repeat Hormone Response Elements
    Akira Takeshita, Yasunori Ozawa, William W. Chin · 2000 · Endocrinology
  145. EMBO Retinoids 2011: Mechanisms, Biology and Pathology of Signaling by Retinoic Acid and Retinoic Acid Receptors
    McKenna, Neil J. · 2012 · Nuclear Receptor Signaling
  146. A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma
    William J. Berg, Lawrence Howard Schwartz, Alison Amsterdam · 1997 · Investigational New Drugs
  147. Retinoids and their target genes in liver functions and diseases
    Goshi Shiota, Keita Kanki · 2013 · Journal of Gastroenterology and Hepatology
  148. Retinoic acid increases proliferation rate of GL‐15 glioma cells, involving activation of STAT‐3 transcription factor
    Éléna Paillaud, Sílvia Lima Costa, C. Fages, Jean‐Luc Plassat, Cécile Rochette‐Egly, Christelle Monville, M. Tardy · 2002 · Journal of Neuroscience Research
  149. RARα2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma
    Siqing Wang, Guido J. K. Tricot, Lei Shi, Wei Xiong, Zhaoyang Zeng, Hongwei Xu, Maurizio Zangari, Bart Barlogie, John D. Shaughnessy, Fenghuang Zhan · 2009 · Blood
  150. Vitamin A deficiency in an infant with PAGOD syndrome
    Ralitza H. Gavrilova, Nikola Babovic, Aida Nadim Lteif, Benjamin W. Eidem, Salman Kirmani, Timothy M. Olson, Dusica Babovic‐Vuksanovic · 2009 · American Journal of Medical Genetics Part A
  151. All‐trans retinoic acid shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells
    G Zauli, Giuseppe Visani, Marco Vitale, Davide Gibellini, Lucia Bertolaso, Silvano Capitani · 1995 · British Journal of Haematology
  152. Vinexinβ, an atypical “sensor” of retinoic acid receptor γ signaling: union and sequestration, separation, and phosphorylation
    Lalevee, Sébastien, Bour, Gaétan, Quinternet, Marc, Samarut, Eric, Kessler, Pascal, Vitorino, Marc, Bruck, Nathalie, Delsuc, Marc‐André, Vonesch, Jean‐Luc, Kieffer, Bruno et al. · 2010 · The FASEB Journal
  153. Small Ubiquitin-Like Modifier-2 Modification of Retinoic Acid Receptor-α Regulates Its Subcellular Localization and Transcriptional Activity
    Zhu, Li, Santos, Nadine C., Kim, Kwan Hee · 2009 · Endocrinology
  154. Retinoid Signaling in Cancer and Its Promise for Therapy
    Krysta Mila Coyle · 2013 · Journal of Carcinogenesis & Mutagenesis
  155. Localization of the chromosome 15 breakpoints and expression of multiple PML-RAR alpha transcripts in acute promyelocytic leukemia: a study of 28 Chinese patients.
    Jie Geng, J H Tong, Shuo Dong · 1993 · PubMed
  156. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
    Guisheng Yang, M.D. Minden, E. A. McCulloch · 1994 · PubMed
  157. Identification of DNA rearrangements at the retinoic acid receptor- alpha (RAR-alpha) locus in all patients with acute promyelocytic leukemia (APL) and mapping of APL breakpoints within the RAR-alpha second intron. Italian Cooperative Study Group "GIMEMA"
    Daniela Diverio, F Lo Coco, Francesca D'adamo · 1992 · Blood
  158. A New Rexinoid for Cutaneous T-Cell Lymphoma
    Sola X. Cheng, Thomas Seth Kupper · 2001 · Archives of Dermatology
  159. Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer
    F. Recchia, Gaetano Saggio, Alisia Cesta et al. · 2006 · Cancer Immunology Immunotherapy
  160. Combination of all-trans retinoic acid and interferon-gamma upregulated p27kip1 and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells
    Ran Zhang, Naren Lal Banik, Swapan K. Ray · 2007 · Cancer Chemotherapy and Pharmacology
  161. Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial
    Eric M. Cheung, Jacek Pinski, Tanya Barauskas Dorff et al. · 2009 · Clinical Genitourinary Cancer
  162. Reduced retinoid content in hepatocellular carcinoma with special reference to alcohol consumption
    Sadashi Adachi, Hisataka Moriwaki, Yasutoshi Muto · 1991 · Hepatology
  163. MicroRNAs
    Mir Farshid Alemdehy, Stefan J. Erkeland · 2012 · Current Opinion in Hematology
  164. Receptor Specificity of Retinoid-Induced Epidermal Hyperplasia: Effect of RXR-Selective Agonists and Correlation with Topical Irritation
    Scott M. Thacher, Andrew M. Standeven, Jyothi Athanikar, Scott C. Kopper, Oliver Castilleja, Maria Escobar, Richard L. Beard, Roshantha A.S. Chandraratna · 1997 · Journal of Pharmacology and Experimental Therapeutics
  165. A Novel RARβ Isoform Directed by a Distinct Promoter P3 and Mediated by Retinoic Acid in Breast Cancer Cells
    Xinjian Peng, Takeshi Maruo, Yanxia Cao · 2004 · Cancer Research
  166. High concentrations of retinoids induce differentiation and late apoptosis
    Tarek H. El‐Metwally, Mahmoud R. Hussein, Parviz M. Pour · 2005 · Cancer Biology & Therapy
  167. Effect of stanol ester on postabsorptive squalene and retinyl palmitate
    Heikki Relas, Helena K. Gylling, Tatu A. Miettinen · 2000 · Metabolism
  168. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide
    Silvia Panigone, Silvana Debernardi, Yoichi Taya · 2000 · Oncogene
  169. Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents
    Valeria Santini, Ari M. Melnick, Jaroslaw Pawel Maciejewski, Estelle Duprez, Clara Nervi, Lucio Cocco, Kevin G. Ford, Ghulam Jeelani Mufti · 2013 · Critical Reviews in Oncology/Hematology
  170. Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study
    F. Recchia, Ferdinando di Orio, Giampiero Candeloro · 2009 · Gynecologic Oncology
  171. HACE1: A novel repressor of RAR transcriptional activity
    Jianhua Zhao, Zhenping Zhang, Zivjena Vucetic, Kenneth J. Soprano, Dianne Robert Soprano · 2009 · Journal of Cellular Biochemistry
  172. Acinus-S′ Represses Retinoic Acid Receptor (RAR)-Regulated Gene Expression through Interaction with the B Domains of RARs
    Zivjena Vucetic, Zhenping Zhang, Jianhua Zhao, Fang Wang, Kenneth J. Soprano, Dianne Robert Soprano · 2008 · Molecular and Cellular Biology
  173. Chemoprevention of Mammary Cancer by Retinoids
    Richard C. Moon, Rajendra G. Mehta · 1990 · Springer eBooks
  174. Novel agents and incremental advances in the treatment of head and neck cancer
    Fadlo Raja Khuri, Sanjay R. Jain · 2004 · Seminars in Oncology
  175. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells
    Lin Ma, Christriane Gauvillé, Yolande Berthois, Armelle Degeorges, Guy Millot, Pierre‐Marie Martin, Fabien M. Calvo · 1998 · International Journal of Cancer
  176. The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription
    Karel H. M. van Wely, Magda A. Meester‐Smoor, Marjolein J. F. W. Janssen, A-J Aarnoudse, Gerard C. Grosveld, Ellen C. Zwarthoff · 2007 · Oncogene
  177. Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma
    Gu, Jing-li, Li, Juan, Zhou, Zheng-hai, Liu, Jun-ru, Huang, Bei-hui, Zheng, Dong, Su, Chang · 2012 · Biochemical and Biophysical Research Communications
  178. Phosphorylation of the retinoic acid receptor RARγ2 is crucial for the neuronal differentiation of mouse embryonic stem cells
    Ziad Al Tanoury, Samia Gaouar, Aleksandr Piskunov, Tao Ye, Sylvia Urban, Bernard Jost, Céline Keime, Irwin Davidson, Andrée Dierich, Cécile Rochette‐Egly · 2014 · Journal of Cell Science
  179. Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells
    Q Wu, Xiaohe Lin, XF Ye, B Zhang, Z Xie, Wang Hui Su · 2004 · Journal of Molecular Endocrinology
  180. Coordinated repressive chromatin-remodeling of Oct4 and Nanog genes in RA-induced differentiation of embryonic stem cells involves RIP140
    Cheng‐Ying Wu, Xudong Feng, Li‐Na Wei · 2014 · Nucleic Acids Research
  181. Coordination of transcription of the human 17 beta-hydroxysteroid dehydrogenase type 1 gene (EDH17B2) by a cell-specific enhancer and a silencer: identification of a retinoic acid response element.
    Yun-shang Piao, Hellevi Peltoketo, Jouko Oikarinen · 1995 · Molecular Endocrinology
  182. RARγ is required for correct deposition and removal of Suz12 and H2A.Z in embryonic stem cells
    Ramon Amat, Lorraine J. Gudas · 2010 · Journal of Cellular Physiology
  183. Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressure
    Robert E. Gallagher, Esther L. Schachter-Tokarz, D-C Zhou · 2006 · Leukemia
  184. The Expression of Retinoic Acid Receptors and the Effects in Vitro by Retinoids in Human Pancreatic Cancer Cell Lines
    Elin Albrechtsson, Bodil Ohlsson, Jan Axelson · 2002 · Pancreas
  185. Role of vitamin A elimination or supplementation diets during postnatal development on the allergic sensitisation in mice
    Ralph Rühl, Andrej Hänel, Ada L. García, Anja Dahten, Udo Herz, Florian J. Schweigert�, Margitta Worm · 2007 · Molecular Nutrition & Food Research
  186. High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia
    Yinjun Lou, Wenbin Qian, Haitao Meng · 2012 · Leukemia Research
  187. Pilot Phase II Trial of 13-cis-Retinoic Acid and Interferon-α Combination Therapy for Advanced Pancreatic Adenocarcinoma
    Dennis Frederic Moore, Richard M. Pazdur, Steve Sugarman · 1995 · American Journal of Clinical Oncology
  188. Multidirectional interplay between nuclear receptors and microRNAs
    Deo Prakash Pandey, Didier Picard · 2010 · Current Opinion in Pharmacology
  189. Modulation of Retinoic Acid Receptor Alpha Activity by Lysine Methylation in the DNA Binding Domain
    M. D. Mostaqul Huq, Sung Gil Ha, Li‐Na Wei · 2008 · Journal of Proteome Research
  190. Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer
    G.J.S. Rustin, Timothy George Quinnell, J Johnson · 1996 · British Journal of Cancer
  191. Inhibition of Mammary Carcinoma Growth by Retinoidal Benzoic Acid Derivatives
    Joseph A. Fontana, Peter D. Hobbs, Marcia I. Dawson · 2008 · Experimental Cell Biology
  192. N -(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1 -mutated breast cancer cells
    Ann‐Marie Simeone, Chu‐Xia Deng, Gary J. Kelloff, Vernon E. Steele, Marcella M. Johnson, Ana Maria Tari · 2005 · Carcinogenesis
  193. Retinoic acid-receptor activation of SP-B gene transcription in respiratory epithelial cells
    Cong Yan, Manely Ghaffari, Jeffrey A. Whitsett, Xin Zeng, Zvjezdana Sever-Chroneos, Sui Lin · 1998 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  194. Retinoids in the treatment of glioma: a new perspective
    Anthony R. Mawson · 2012 · Cancer Management and Research
  195. PTOV1 antagonizes MED25 in RAR transcriptional activation
    HyeSook Youn, Ui‐Hyun Park, Eunjoo Kim, Soo‐Jong Um · 2010 · Biochemical and Biophysical Research Communications
  196. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid
    Wen G. Jiang, Wentao Deng, Sarah K Bailey, C D Nail, Andra R. Frost, Wayne J. Brouillette, Donald D. Muccio, Clinton J. Grubbs, Susan M. Lobo-Ruppert, John Michael Ruppert · 2009 · Cancer Biology & Therapy
  197. Formation of Retinoylated Proteins from Retinoyl-CoA in Rat Tissues
    Yoshinori Kubo, Masashi Wada, Toshihiro Ohba · 2005 · The Journal of Biochemistry
  198. Liganded RARα and RARγ interact with but are repressed by TNIP1
    Igor Gurevich, Brian J. Aneskievich · 2009 · Biochemical and Biophysical Research Communications
  199. The Association of Retinoic Acid Receptor Beta2(RARβ2) Methylation Status and Prostate Cancer Risk: A Systematic Review and Meta-Analysis
    Tianyi Gao, Bangshun He, Yuqin Pan, Rui Li, Yeqiong Xu, Liping Chen, Zhenling Nie, Ling Gu, Shukui Wang · 2013 · PLoS ONE
  200. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma
    Ying Y Liu, Marcel P. M. Stokkel, Hans A. Morreau · 2007 · Clinical Endocrinology